Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support in IVF/ICSI
2018-000105-23Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of dydrogesterone and progesterone in female infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Molecular endometrial difference between oral dydrogesterone and micronized vaginal progesterone. Started Nov 2018; status: completed.
02
Drugs
dydrogesteroneprogesterone
03
Conditions
female infertility
Beyond the preview
Go deeper on 2018-000105-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000105-23.